31 Mar 2019
Assets8.55
Total Income2.76
EBITDA0.32
Profit After Tax0.00
NET Worth0.60
Reserves and Surplus0.45
Total Borrowing2.52
Open 31st Dec 2021 · Close 5th Jan 2022 · Listing 13th Jan 2022
The shares listed at ₹38.45, a 6.81% move from the issue price. Fabino Life Sciences is a SME IPO with an issue size of ₹3.24 crore, proposed for listing on BSE SME. The offer opens on 31st Dec 2021 and closes on 5th Jan 2022. The issue structure includes a fresh issue of ₹3.07 crore. The current listing schedule points to 13th Jan 2022.
| Investor | Lots | Shares | Amount |
|---|---|---|---|
| Minimum Bid | 1 | 3000 | — |
| Object | Amount |
|---|---|
| Part Repayment of Loans | ₹0.25 Cr |
| Funding Working capital requirements | ₹2.05 Cr |
| General Corporate Purpose | ₹0.50 Cr |
| Expense | Amount |
|---|---|
| Issue Management fees including fees and payment to other intermediaries such as Legal Advisors, Registrars and other out of pocket expenses. | ₹0.34 Cr |
| Brokerage and selling commission | ₹0.00 Cr |
| Printing & Stationery, Distribution, Postage, etc. | ₹0.02 Cr |
| Advertisement and Marketing Expenses | ₹0.02 Cr |
| Stock Exchange Fees, Regulatory and other Expenses | ₹0.07 Cr |